palmidrol has been researched along with Bowel Diseases, Inflammatory in 6 studies
palmidrol: a cannabinoid receptor-inactive eCB-related molecule used as prophylactic in helping to prevent respiratory viral infection
palmitoyl ethanolamide : An N-(long-chain-acyl)ethanolamine that is the ethanolamide of palmitic (hexadecanoic) acid.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The goal of the current study was to explore the effects of adelmidrol, an analog of the anti-inflammatory fatty acid amide signaling molecule palmitoylethanolamide, in mice subjected to experimental colitis." | 3.83 | Adelmidrol, a Palmitoylethanolamide Analogue, as a New Pharmacological Treatment for the Management of Inflammatory Bowel Disease. ( Cordaro, M; Crupi, R; Cuzzocrea, S; Esposito, E; Gugliandolo, E; Impellizzeri, D; Siracusa, R, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Cordaro, M | 2 |
| Scuto, M | 1 |
| Siracusa, R | 2 |
| D'amico, R | 1 |
| Filippo Peritore, A | 1 |
| Gugliandolo, E | 2 |
| Fusco, R | 1 |
| Crupi, R | 2 |
| Impellizzeri, D | 2 |
| Pozzebon, M | 1 |
| Alfonsi, D | 1 |
| Mattei, N | 1 |
| Marcolongo, G | 1 |
| Evangelista, M | 1 |
| Cuzzocrea, S | 2 |
| Di Paola, R | 1 |
| Esposito, G | 2 |
| Pesce, M | 1 |
| Seguella, L | 1 |
| Lu, J | 1 |
| Corpetti, C | 1 |
| Del Re, A | 1 |
| De Palma, FDE | 1 |
| Sanseverino, W | 1 |
| Sarnelli, G | 1 |
| Couch, DG | 2 |
| Tasker, C | 1 |
| Theophilidou, E | 1 |
| Lund, JN | 2 |
| O'Sullivan, SE | 2 |
| Cook, H | 1 |
| Ortori, C | 1 |
| Barrett, D | 1 |
| Alhouayek, M | 1 |
| Bottemanne, P | 1 |
| Subramanian, KV | 1 |
| Lambert, DM | 1 |
| Makriyannis, A | 1 |
| Cani, PD | 1 |
| Muccioli, GG | 1 |
| Esposito, E | 1 |
1 trial available for palmidrol and Bowel Diseases, Inflammatory
| Article | Year |
|---|---|
Palmitoylethanolamide and Cannabidiol Prevent Inflammation-induced Hyperpermeability of the Human Gut In Vitro and In Vivo-A Randomized, Placebo-controlled, Double-blind Controlled Trial.
Topics: Adolescent; Adult; Amides; Anti-Inflammatory Agents, Non-Steroidal; Caco-2 Cells; Cannabidiol; Cell | 2019 |
5 other studies available for palmidrol and Bowel Diseases, Inflammatory
| Article | Year |
|---|---|
Effect of N-palmitoylethanolamine-oxazoline on comorbid neuropsychiatric disturbance associated with inflammatory bowel disease.
Topics: Amides; Animals; Body Weight; Calcium-Binding Proteins; Dextran Sulfate; Ethanolamines; Glial Cell L | 2020 |
Engineered
Topics: Amides; Animals; Colitis; Dextran Sulfate; Disease Models, Animal; Ethanolamines; Humans; Inflammati | 2021 |
Cannabidiol and palmitoylethanolamide are anti-inflammatory in the acutely inflamed human colon.
Topics: Acute Disease; Amides; Anti-Inflammatory Agents; Caco-2 Cells; Cannabidiol; Colon; Cytokines; Ethano | 2017 |
N-Acylethanolamine-hydrolyzing acid amidase inhibition increases colon N-palmitoylethanolamine levels and counteracts murine colitis.
Topics: Amides; Amidohydrolases; Animals; Anti-Inflammatory Agents; Arachidonic Acids; Chromatography, High | 2015 |
Adelmidrol, a Palmitoylethanolamide Analogue, as a New Pharmacological Treatment for the Management of Inflammatory Bowel Disease.
Topics: Amides; Animals; Anti-Inflammatory Agents; Apoptosis; Body Weight; Colitis; Cyclooxygenase 2; Cytoki | 2016 |